Search

BACKGROUND: Liver metastases is a pivotal factor of death in patients with colorectal cancer. The longitudinal data of colorectal liver metastases (CRLM) during treatment can monitor and reflect treatment efficacy and outcomes. OBJECTIVE: The objective of this study is to establish a radiomic model based on longitudinal magnetic resonance imaging (MRI) to predict chemotherapy response in patients with CRLM. METHODS: This study retrospectively enrolled longitudinal MRI data of five modalities on 100 patients. According to Response Evaluation Criteria in Solid Tumors (RECIST 1.1), 42 and 58 patients were identified as responders and non-responders, respectively. First, radiomic features were computed from different modalities of image data acquired pre-treatment and early-treatment, as well as their differences (Δ). Next, the features were screened by a two-sample t-test, max-relevance and min-redundancy (mRMR), and least absolute shrinkage and selection operator (LASSO). Then, several ensemble radiomic models that integrate support vector machine (SVM), k-nearest neighbor (KNN), gradient boost decision tree (GBDT) and multi-layer perceptron (MLP) were established based on voting method to predict chemotherapy response. Data samples were divided into training and verification queues using a ratio of 8:2. Finally, we used the area under ROC curve (AUC) to evaluate model performance. RESULTS: Using the ensemble model developed using featue differences (Δ) computed from the longitudinal apparent diffusion coefficient (ADC) images, AUC is 0.9007±0.0436 for the training cohort. Applying to the testing cohort, AUC is 0.8958 and overall accuracy is 0.9. CONCLUSIONS: Study results demonstrate advantages and high performance of the ensemble radiomic model based on the radiomics feature difference of the longitudinal ADC images in predicting chemotherapy response, which has potential to assist treatment decision-making and improve clinical outcome. [ABSTRACT FROM AUTHOR]

Background: There is a shortage of clinicians with sufficient expertise in the diagnosis of Alzheimer's disease (AD), and cerebrospinal fluid biometric collection and positron emission tomography diagnosis are invasive. Therefore, it is of potential significance to obtain high-precision automatic diagnosis results from diffusion tensor imaging (DTI) through deep learning, and simultaneously output feature probability maps to provide clinical auxiliary diagnosis. Objective: We proposed a factorization machine combined neural network (FMCNN) model combining a multi-function convolutional neural network (MCNN) with a fully convolutional network (FCN), while accurately diagnosing AD and mild cognitive impairment (MCI); corresponding fiber bundle visualization results are generated to describe their status. Methods: First, the DTI data is preprocessed to eliminate the influence of external factors. The fiber bundles of the corpus callosum (CC), cingulum (CG), uncinate fasciculus (UNC), and white matter (WM) were then tracked based on deterministic fiber tracking. Then the streamlines are input into CNN, MCNN, and FMCNN as one-dimensional features for classification, and the models are evaluated by performance evaluation indicators. Finally, the fiber risk probability map is output through FMCNN. Results: After comparing the model performance indicators of CNN, MCNN, and FMCNN, it was found that FMCNN showed the best performance in the indicators of accuracy, specificity, sensitivity, and area under the curve. By inputting the fiber bundles of the 10 regions of interest (UNC_L, UNC_R, UNC, CC, CG, CG+UNC, CG+CC, CC+UNC, CG+CC+UNC, and WM into CNN, MCNN, and FMCNN, respectively), WM shows the highest accuracy in CNN, MCNN, and FMCNN, which are 88.41%, 92.07%, and 96.95%, respectively. Conclusion: The FMCNN proposed here can accurately diagnose AD and MCI, and the generated fiber probability map can represent the risk status of AD and MCI. [ABSTRACT FROM AUTHOR]

Schwannoma (SCH) and meningiomas (MEN) are the two most common primary spinal cord tumors. Differentiating between them preoperatively remains a clinical challenge due to the substantial overlap in their clinical presentation and imaging characteristics.The objective of this study is to facilitate early diagnosis of patients and reduce clinician stress by constructing a deep learning-based classification model for automatic diagnosis of schwannoma and meningiomas using magnetic resonance images (MRI).We retrospectively collected MRI images of 74 patients with pathologically confirmed schwannoma and meningiomas from 2015 to 2020 at a local hosipital, and constructed a CNN model based on the PyTorch's deep learning framework for the discrimination between the two. First, a modified feature fusion CNN model (ResNet34-SKConv) was trained by introducing a selective convolutional kernel module into the original CNN model. The introduction of the selective convolutional kernel module enhances the network's focus on tumor features and effectively improves the network's performance. Finally, the trained model was used to process all the MRI image slices to achieve the classification of SCH and MEN patients by the voting prediction method.Using the 5-fold cross-validation method, this new ResNet34-SKConv model achieves a classification accuracy of 92.32%, a specificity of 95.87%, and a F1-score of 93.54, respectively.This study demonstrated that a classification model using a deep learning network can be effective in achieving differential diagnosis of SCH and MEN. Thus, the new method has great potential for developing new computer-aided diagnosis and applications with future clinical practice. [ABSTRACT FROM AUTHOR]